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Available online 29 November 2010In the present study, we describe the cardiovascular effects of local acetylcholine (Ach)
microinjection into both the ventrolateral (vlPAG) and dorsal (dPAG) periaqueductal gray
areas of anesthetized rats and the possible local receptors involved with these responses.
Microinjection of Ach (9, 27, 45 or 81 nmol/50 nL) into the vlPAG caused dose-related
depressor responses. These hypotensive responses were blocked by local pretreatment with
increasing doses of the nonselective muscarinic antagonist atropine (1, 3 or 9 nmol/50 nL).
The microinjection of Ach into the dPAG caused no significant cardiovascular responses in
anesthetized rats. In conclusion, the present findings suggest that a cholinergic system
present in the vlPAG, but not in the dPAG, is involved with cardiovascular system control.
Moreover, these cardiovascular responses evoked by Ach are mediated by muscarinic
receptors.
© 2010 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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The periaqueductal gray area (PAG) is a mesencephalic region
that integrates behavioral and cardiovascular responses in
rodents (Huang et al., 2000; Jenck et al., 1989; Nashold et al.,
1969). The PAG is functionally subdivided into four longitudinal
columns along its rostrocaudal axis: the dorsomedial, dorsolat-
eral, lateral and ventrolateral columns (Bandler et al., 1991).
PAG neurons present projections to numerous structures
involved in cardiovascular regulation, among them the rostral
ventrolateral medulla (RVLM) (Chen and Aston-Jones, 1995;
Farkas et al., 1998; Van Bockstaele et al., 1989). Particulary,
electrical stimulation of the dorsal PAG (dPAG) increases
arterial pressure through a sympathoexcitatory action (Kubo
et al., 1999). However, electrical stimulation of the dorsal,Ribeirão Preto, University
ax: +55 16 6332301.
 the Elsevier OA license.dorsolateral or lateral PAG evokes hypertension, tachycardia
and hindlimb vasodilatation in anesthetized rats (Hamalainen
and Lovick, 1997; Lovick, 1992a). Additionally, microinjection of
DL-homocysteic acid into the dPAG of anesthetized rats has
been reported to cause hypertension and tachycardia, whereas
depressor and bradycardiac responses have been observed after
its injection into the ventrolateral PAG of anesthetized rats
(vlPAG) (Bandler et al., 1991; Huang et al., 2000; Lovick, 1985,
1992a; Rossi et al., 1994). Therefore, pressor responses are
evoked by dorsal and lateral columns in PAG stimulation,
whereas depressor and bradycardiac responses are evokedafter
stimulation of the ventrolateral PAG (Carrive and Bandler, 1991;
Carrive et al., 1989; Lovick, 1992a; Rossi et al., 1994).
Interestingly, Pelosi and Correa (2005) reported that the
microinjection of noradrenaline (NA) into either the vlPAG orof São Paulo, Department of Pharmacology, Av. Bandeirantes 3900,
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unanesthetized rats (Pelosi et al., 2008).
It has been described that cholinergic systems of several
brain regions are involved in cardiovascular modulation,
among them those in the lateral septal area (Scheucher
et al., 1987), the posterior hypothalamus (Brezenoff and Xiao,
1989), the nucleus of the solitary tract (Sundaram et al., 1989)
and the medial prefrontal cortex (Crippa et al., 1999).
There are results showing the presence of both cholinergic
synapses andmuscarinic receptors in the PAG (Wamsley et al.,
1981). Because a cholinergic system is present in the PAG, and
this brain area is involved in central cardiovascular modula-
tion, it is possible to suggest that such PAG cholinergic
neurotransmission could also modulate the cardiovascular
system. However, there are no reports on the cardiovascular
effects of local injection of Ach into the PAG, and particularly
into the dPAG or the vlPAG at different rostrocaudal coordi-
nates, in the rat brain.
Therefore, the present work examined the cardiovascular
effects of local Ach microinjection into the vlPAG and dPAG
columns of anesthetized rats and the subtype of cholinergic
receptors that mediate these responses.Fig. 1 – Changes in mean arterial pressure (ΔMAP) and heart
rate (ΔHR) in response to the microinjection of Ach (9, 27, 45
and 81 nmol/50 nL n=20) in the different rostrocaudal
coordinates of the vlPAG of anesthetized rats. Columns
represent the means and bars the SEM. Dose–effect curves
were generated by nonlinear regression analysis and were
statistically significant. (ΔMAP, r2=0.92; *P>0.05).2. Results
2.1. Cardiovascular response to the microinjection of
different doses of Ach into the different rostrocaudal
coordinates of the vlPAG of anesthetized rats
The basal levels of both MAP and HR of the rats used to
generate the dose–response curves were, respectively, 91±
3 mmHg and 390±8 bpm (n=20).
Microinjections of Ach (9, 27, 45 and 81 nmol/50 nL) into the
rostral, medial and caudal portions of the vlPAG of anesthe-
tized rats caused dose-related MAP decreases (r2=0.92,
*P<0.05) (Fig. 1). However, no significant HR changes were
observed even at the highest dose of Ach (81 nmol/50 nL)
(before: HR=390±12 bpm and after: HR=392±11 bpm; n=5,
t=0.58, P>0.05). The estimated ED50 was approximately
45 nmol/50 nL for the depressor response.
The depressor response (ΔMAP=−17±2.5 mmHg, n=6)
evoked by microinjection of Ach (45 nmol/50 nL) into the
vlPAG was significantly different from those effects observed
by injection of 50 nL of ACSF (n=5; t=9, P<0.05). In addition,
the microinjection of Ach (45 nmol/50 nL) into the dorsal
raphe nucleus and laterodorsal tegmental nucleus (outside
the vlPAG) did not cause significant changes in either MAP
(before: 93 ± 2.7 mmHg and after: 92.5 ± 3.mmHg; n=5, P>0.05,
t=0.7) or HR (before: 391 ± 5.4 bpm and after: 394 ± 5 bpm; n=5,
t=0.9, P>0.05).
2.2. Cardiovascular response to the microinjection of
different doses of Ach into the different rostrocaudal
coordinates of the dPAG of anesthetized rats
The basal levels of both MAP and HR of the rats used to
generate the dose–response curves were respectively 93±
3 mmHg and 394±7 bpm (n=12).Microinjection of Ach (9, 27, 45 or 81 nmol/50 nL) into the
rostral, medial or caudal portions of the dPAG did not affect
either MAP (r2=0.3, P>0.05) or HR (r2=0.4, P>0.05).
2.3. Effect of local pretreatment with ACSF or different
doses of atropine on blood pressure response to Ach
microinjection into the vlPAG of anesthetized rats
2.3.1. Vehicle
Pretreatment of the vlPAG with 50 nL of ACSF (n=5) did not
affect basal levels of either MAP (before: 92±4.4 mmHg and
after: 94±1.2 mmHg, t=0.64, P>0.05) or HR (before: 405±
9.2 bpm and after: 403±6.8 bpm, t=0.45, P>0.05). Moreover,
the pretreatment with ACSF did not affect the hypotensive
response evoked by Ach (45 nmol/50 nL) into the vlPAG (ΔMAP
before ACSF=−17.3±2 mmHg and ΔMAP after ACSF=−16.9±
2.3 mmHg; n=5, t=0.8, P>0.05).
2.3.2. Atropine
Inhibition of MAP responses by the microinjection of Ach
(45 nmol/50 nL) into the vlPAG after local pretreatment with
different doses of the nonselective muscarinic receptor
antagonist atropine (1, 3 and 9 nmol, n=4 for each dose).
Fig. 2 – Inhibition of MAP responses (expressed as %) by the
microinjection of Ach (45 nmol/50 nL) into the vlPAG after
local pretreatment with different doses of atropine
antagonist (1, 3 and 9 nmol, n=4 for each dose). Curves
were generated by nonlinear regression analysis. Symbols
represent means and vertical lines indicate the S.E. mean.
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basal levels of either MAP (MAP before atropine: 90±1.7 mmHg
and after: 91±2.1 mmHg; n=12, t=1.1, P>0.05) or HR (before
atropine: 398±9 bpm and after: 399±6 bpm; n=12, t=0.9,
P>0.05).
Pretreatment of the vlPAG with 3 nmol/50 nL did not affect
basal levels of either MAP (MAP before atropine: 90±2.5 mmHg
and after: 93±3 mmHg; n=12, t=1.1, P>0.05) or HR (before
atropine: 402±7.2 bpm and after: 399±6.5 bpm; n=12, t=0.9,
P>0.05).
Pretreatment of the vlPAG with 9 nmol/50 nL did not affect
basal levels of either MAP (MAP before atropine: 92±2.3 mmHg
and after: 93±2 mmHg; n=12, t=1.1, P>0.05) or HR (before
atropine: 391±5.7 bpm and after: 387±6.8 bpm; n=12, t=0.9,
P>0.05).
Local pretreatment with atropine (1, 3 and 9 nmol/50 nL)
caused a dose-related inhibition (r2 = 0.9) of depressor
responses to Ach microinjection into the vlPAG (Fig. 2). The
higher dose of atropine inhibited 92±3% of the Ach depressor
response.
In addition, pretreatment with 9 nmol/50 nL injected into
the dorsal raphe nucleus and laterodorsal tegmental nucleus
(outside the vlPAG) did not cause inhibition of depressor
responses to Ach in the vlPAG (ΔMAP before: −18 ± 2.7 mmHg
and after: −16.5 ± 3 mmHg; n=4, P>0.05, t=0.7).
Recordings from a representative anesthetized rat showing
the effects of injection of Ach (45 nmol/50 nL) into the vlPAG
on both the mean or pulsatile arterial pressure as well as the
heart rate, before and 10 min after local pretreatment of the
vlPAG with 1 nmol/50 nL of atropine (A), 3 nmol/50 nL (B) and
9 nmol/50 nL (C) are presented in Fig. 3.
2.4. Effect of systemic (i.v.) pretreatment with atropine
on the blood pressure response to Ach microinjection into
the vlPAG of anesthetized rats
The systemic i.v. administration of the same dose of atropine
(9 nmol) microinjected into the vlPAG did not affect basallevels of either MAP (before atropine: 90±2.4 mmHg and after:
92.3±2.3 mmHg; n=6 t=1, P>0.05) or HR (before atropine: 394±
9 bpm and after: 397±7 bpm; n=6, t=0.84, P>0.05). Systemic
pretreatment with atropine did not affect the hypotensive
response evoked by microinjection of 45 nmol of Ach into the
vlPAG (ΔMAP before atropine=−18±5 mmHg and ΔMAP after
atropine=−19±4 mmHg; t=0.5, P>0.05, n=6).
2.5. The distribution of injection sites
The distribution of injection sites in the dPAG, vlPAG and
outside the vlPAG of all animals used are presented in Fig. 4 A
and B, respectively. Photomicrographs illustrating sites of
injection in the dPAG and vlPAG are presented in Fig. 5A and B,
respectively.3. Discussion
In the present study, we report that microinjection of Ach into
the rostral, medial and caudal portions of the vlPAG of
anesthetized rats evoked dose-dependent hypotensive
responses. However, no significant cardiovascular changes
were observed after its injection into the rostral, medial or
caudal portions of the dPAG.
Mapping of PAG areas in which chemical stimulation
evoked cardiovascular responses was performed in both cats
and rats and indicated that the PAG is organized as rostro-
caudal columns (Carrive and Bandler, 1991; Lovick, 1985,
1992a). Such organization may explain why different cardio-
vascular responses were observed when Ach was microin-
jected into different portions of the PAG. The depressor
responses observed when Ach was microinjected into the
vlPAG were similar to those reported after the injection of DL-
homocysteic acid into the same area (Bandler et al., 1991;
Huang et al., 2000; Lovick, 1985, 1992a; Rossi et al., 1994).
The fact that no significant HR changes were observed after
its microinjection into the vlPAG could be a consequence of an
impaired baroreflex response. Baroreflex activity has been
reported to be blunted under anesthesia (Crippa et al., 2000;
Fluckiger et al., 1985; Shimokawa et al., 1998), thus reducing the
range of ΔHR changes and resulting in smaller reflex responses.
Studies using tracing techniques have indicated that
several brain regions, including the PAG, provide afferent
inputs to the RVLM (Van Bockstaele et al., 1991). The PAG is
thought to be involved in cardiovascular control, perhaps via a
relay in the RVLM (Carrive et al., 1989; Keay et al., 2000; Lovick,
1992b; Verberne and Struyker Boudier, 1991). Neurons in the
vlPAG have been retrogradely labeled when a tracer was
injected into the RVLM and hypotensive responses observed
after its stimulation seem to be mediated by an inhibition of
those pressor neurons (Carrive and Bandler, 1991). In addition,
the vlPAG is also connected with depressor regions in the
caudal midline medulla and caudal ventrolateral medulla,
which may in part contribute to the vlPAG-mediated hypo-
tension (Henderson et al., 1998).
According to Bandler and Shipley (1994), the vlPAG
participates in the organization of more passive responses
that tend to reduce the physiological and emotional impact of
Fig. 3 – Recordings of a representative anesthetized rat showing the effects on mean arterial pressure (MAP), pulsatile arterial
pressure (PAP), and heart rate (HR) of the injection of 45 nmol/50 nL Ach into the vlPAG, before and 10 min after local
pretreatment of the vlPAG with 1 nmol/50 nL of atropine (A), 3 nmol/50 nL (B) and 9 nmol/50 nL (C).
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coordinates autonomic correlates of defense reactions
(Depaulis et al., 1994; Zhang et al., 1990). The activation of
neurons in the vlPAG evokes a decrease in the arterial
pressure as well as changes in the vasoconstrictor sympa-
thetic tonus (Carrive and Bandler, 1991). Monassi and collea-
gues (1997) reported that the microinjection of a cholinergic
agonist into the vlPAG increased the duration of tonic
immobility episodes. The cholinergic system in the PAG hasalso been reported to be activated in subordinate rats during
encounters that result in social defeat (Kroes et al., 2007).
Conversely, stimulation of the vlPAG evokes submissive
behavior. In most cases these behavioral changes are accom-
panied by a decrease in the arterial pressure (Carli, 1974).
Although there is no clear evidence of the mechanism
involved in the mediation of the hypotensive response to the
injection of Ach into the vlPAG, thismechanismmay involve an
inhibition of the sympathetic nervous system. Neurons in the
Fig. 4 – Diagrammatic representation of rat brain frontal sections modified from the atlas of Paxinos and Watson (1997),
indicating the sites of microinjection: A) exclusively into the dPAG (closed circles), B) vlPAG of anesthetized rats (closed circles)
and outside of vlPAG (open circles). SC, superior colliculus; IC, inferior colliculus; DRD, dorsal raphe nucleus; LDTg, laterodorsal
tegmental nucleus; IA, distance from the interaural line.
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tory region of the RVLM (Carrive et al., 1988). Experimental
evidence indicates that themicroinjection of Ach into the dPAG
causes a pressor response in anesthetized rats (Pizzirusso et al.,
1998) However, in the present report no significant cardiovas-
cular changes were observed after the microinjection of Ach
into this area. One possible explanation is that in Pizzirusso's
study, Ach could be reaching areas outside the dPAG as a result
of the higher volume used (100 nL). Additionally, earlier studieshave shown that cardiovascular responses can be evoked after
chemical stimulation of the superior colliculus, a site very close
to the dPAG (Keay et al., 1988; Pelosi et al., 2007).
There is a dense plexus of cholinergic nerve terminals in the
PAG (Woolf et al., 1990). Acetylcholine's physiological effects
result from the activation of either ligand-gated nicotinic
cholinergic receptors (nAchRs) or G protein-coupled receptors
(mAchRs). There are five subtypes of mAchRs: the M2 and M4
subtypes that are coupled via Gi/o proteins and the M1, M3, and
Fig. 5 – Photomicrograph of coronal rat brain sections showing examples of injection sites in the dPAG (A) and vlPAG (B): dPAG,
dorsal periaqueductal gray; vlPAG, ventrolateral periaqueductal gray; IA,distance from interaural line.
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Themidbrain PAG contains a range ofmAchR subtypes (Aubert
et al., 1996; Yasuda et al., 1993), and so it becomes relevant to
assess the involvement of these receptors in the modulation of
the cardiovascular response to the microinjection of Ach into
the vlPAG. First, we pretreated the vlPAG with the nonselective
muscarinic receptor antagonist atropine, which blocked the
hypotensive effect of Ach, thus suggesting that muscarinic
receptors within the vlPAGmediate the response. The injection
of atropine into the vlPAG caused no effect on baseline blood
pressure, which may indicate that vlPAG cholinergic mecha-
nisms do not exert a tonic influence on cardiovascular control
in anesthetized rats. More specific antagonists such as 4-DAMP
and pirenzepine should be used in future studies to identify the
subtype of muscarinic receptor that mediates the hypotensive
response to the injection of Ach into the vlPAG.
Because Ach is a potent vasodilator, there is a possibility
that the hypotensive effect observed after its microinjection
into the vlPAG could be due to drug spreading from its
injection site to the systemic circulation. However, the idea
that Ach is indeed activating receptors in the vlPAG is favored
by the observation that an i.v. injection of 9 nmol atropine,
which blocked the effect of Achwhen applied to the vlPAG, did
not affect the response to the injection into the vlPAG. In
addition, the microinjection of Ach into the dPAG did not
evoke significant cardiovascular changes, thus suggesting that
the effect observed after its microinjection into the vlPAG is
not consequent to a spreading into the systemic circulation.
In conclusion, our results indicate that a cholinergic system
within the vlPAG is involved in the control of cardiovascular
responses, acting through the activation of local muscarinic
receptors. The results also suggest that the dPAG's cholinergic
mechanism is not involved in the cardiovascular control.4. Experimental procedures
4.1. Animals
Experimental procedures were carried out following protocols
approved by the ethical review committee of the School ofMedicine of Ribeirão Preto, University of São Paulo. Male
Wistar rats weighing 220–260 g (n=38) were used in the
present experiment. Animals were housed in plastic cages in
a temperature-controlled room (25 °C), under a 12:12 h light–
dark cycle. Animals had free access to water and standard
laboratory chow, except during the experimental period. The
Institution's animal ethics committee approved housing
conditions and experimental protocols (protocol 168/2007).
4.2. Surgical preparation
For implantation of stainless steel guide cannulas in the vlPAG or
the dPAG, animals were anesthetized with tribromoethanol
(250 mg/kg i.p., Aldrich Chemical Co. Inc., USA). After local
anesthesia with 2% xylocaine, the skull was surgically exposed
and stainless steel guide cannulas (24 G) were implanted 1mm
above the injection sites using a stereotaxic apparatus (Stoelting,
Wood Dale, IL, USA). Stereotaxic coordinates for cannula
implantation in the vlPAG or the dPAG were selected from the
brain atlas of Paxinos and Watson (1997). The following
coordinates were used: vlPAG: AP=+1.2 mm from the interaural
line, L=+2.5 mm from the medial suture and V=−5.1 mm deep
from the skullwith a lateral inclination of 18°; dPAG: AP=+2.7 mm
from the interaural line, L=+1.5 mm from the medial suture and
V=−4.8 mm deep from the skull with a lateral inclination of 26°.
Cannulas were fixed to the skull with dental cement and one
metal screw. A tight-fitting mandrel was kept inside the guide
cannula toavoid itsocclusion.After surgery, animalswere treated
withapolyantibioticpreparationof streptomycinsandpenicillins
i.m. (Pentabiotico®, Fort Dodge, Brazil) to prevent infection and
with the nonsteroidal anti-inflammatory flunixine meglumine
(2.5 mg kg−1 s.c.; banamine®, Schering Plough, Brazil) for post-
operative analgesia. The cannulawas chronically implanted to be
used for microinjections in anesthetized rats. This approach was
taken to allow potential integration with studies conducted in
unanesthetizedrats standardized inour laboratory.Animalswere
allowed to recover for 48 h.
After the animals were anesthetized with urethane, a
catheter (a 4 cm segment of PE-10 heat-bound to a 13 cm
segment of PE-50, Clay Adams, Parsippany, NJ, USA) was
inserted into the abdominal aorta through the femoral artery
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The absence of somatic motor reflexes in response to tail
pinching or blinking after a low-pressure corneal stimulation
was assumed as indicative of deep anesthesia and analgesia.
Experiments were initiated 1 h after the onset of anesthesia.
4.3. Measurement of cardiovascular response
Arterial pressure (MAP) and heart rate (HR) signals were recorded
using an amplifier (model 7754A, Hewlett Packard, USA) coupled
to a computerized acquisition system (MP100, Biopac, USA).
4.4. Drug injection
A volume of 50 nL was injected using a 1 μl syringe (KH7001;
Hamilton, USA) connected to an injection needle (33-gauge) by a
piece of PE-10 tubing. The microinjection needle was 1 mm
longer than the guide cannula. The volume was controlled by
checking themovement of an air bubble inside the PE-10 tubing.
4.5. Drugs
Acetylcholine (SIGMA) and atropine (SIGMA) were dissolved in
sterile artificial cerebrospinal fluid (ACSF; composition: NaCl
100 mM; Na3PO4 2 mM; KCl 2.5 mM; MgCl2 1 mM; NaHCO3
27 mM; CaCl2 2.5 mM; pH=7.4).
4.6. Experimental design
The first group of animals received injections of increasing
doses of Ach (9, 27, 45 or 81 nmol/50 nL) into the rostral,medial
and caudal portions of the vlPAG to generate a dose–response
curve. Each rat received up to two microinjections with a
10 min interval between them. Resulting data points were
fitted to a dose–response curve. The dose of 45 nmol/50 nLwas
used in the following protocols and 50 nL of ACSF was
microinjected as vehicle control. Numbers of rats used, n=20.
The second group of animals received injections of increas-
ing doses of Ach (9, 27, 45 or 81 nmol/50 nL) into the rostral,
medial or caudal portions of the dPAG to generate a dose–
responsecurve.Eachrat receivedupto twomicroinjectionswith
a 10min interval between them. Resulting data points were
fitted to a dose–response curve. The dose of 45 nmol/50 nL was
used in the following protocols and 50 nL of ACSF was
microinjected as vehicle control. Number of rats used, n=12.
These doses were established from data in the literature
(Pizzirusso et al., 1998).
The third group of animals was used to evaluate the
involvement of muscarinic receptors in the cardiovascular
response to the injection of Ach into the vlPAG. Different doses
of the nonselective muscarinic receptor antagonist atropine
(1, 3 or 9 nmol/50 nL) weremicroinjected into the vlPAG 10 min
before microinjection of Ach. Each animal received only one
dose of atropine. Number of rats used, n=16. These doses were
established from data in the literature (Crippa et al., 1999).
In the last part of the study, we determined whether the
cardiovascular response was due to a central effect of Ach.
Animals received intravenously the same dose of atropine as
injected into the vlPAG (9 nmol) 10min prior to the injection of
45 nmol of Ach into that area. Number of rats used, n=6.4.7. Histological procedure
At the end of the experiments, 50 nL of 1% Evan's blue dye was
injected into the vlPAG or the dPAG as amarker of the injection
site. Animals were submitted to intracardiac perfusion with
0.9% NaCl followed by 10% formalin. Brains were removed and
post-fixed for 48 h at 4 °C and serial 40 μm-thick sections were
cut using a cryostat (CM1900, Leica, Germany). Brain sections
were stained with 1% neutral red for light microscopy analysis.
The actual location of microinjection sites in the area was
determined after the analysis of serial sections and represented
according to the rat brain atlas of Paxinos and Watson (1997).
4.8. Statistical analysis
Nonlinear regression analysis was used to compare MAP and
HR results from different Ach doses microinjected into the
vlPAG or the dPAG. Baseline MAP and HR values were
compared using the paired Student's t test (before treatment
vs. after treatment). Percentages of response inhibition by
vlPAG pretreatment with muscarinic antagonists were ana-
lysed utilizing nonlinear regression analysis. We used Prism
software (GraphPad, USA) to perform statistical analysis.
*P<0.05 was assumed to be statistically significant.Acknowledgments
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